|Day's Range||70.33 - 71.79|
|52 Week Range||65.47 - 111.00|
|PE Ratio (TTM)||926.75|
|Earnings Date||May 25, 2017|
|Dividend & Yield||0.64 (0.90%)|
|1y Target Est||79.62|
TASE: PRGO) today announced that it will conduct a conference call on Tuesday, May 23 at 8:30AM (ET) hosted by John T. Hendrickson, Perrigo's Chief Executive Officer, to discuss the Company's fourth quarter and calendar year 2016 results and its financial statements. Perrigo Company plc, a leading global healthcare company, delivers value to its customers and consumers by providing Quality Affordable Healthcare Products®. Founded in 1887 as a packager of home remedies, Perrigo has built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network.
Incyte rose to one-month high price levels on May 18. Incyte opened higher on Thursday due to positive results from its lung cancer drug.